HealthcareServices

Global Atrial Flutter Market Report 2026–2035: Key Forecasts and Growth Areas

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the atrial flutter market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Atrial Flutter Market between 2026 and 2030?

The atrial flutter market size has seen rapid expansion in recent years. It is projected to expand from $22.99 billion in 2025 to $26.52 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.4%. The historical market growth can be attributed to factors like the increasing prevalence of cardiac arrhythmias, a rising aging population, the expansion of cardiology specialty clinics, the adoption of ecg-based diagnostic tools, and the availability of pharmacological rhythm control therapies.

The atrial flutter market size is projected to experience substantial growth in the coming years. By 2030, it is anticipated to reach $46.47 billion, driven by a compound annual growth rate (CAGR) of 15.0%. This expansion during the forecast period is primarily due to the increasing demand for minimally invasive cardiac procedures, the rising adoption of digital cardiac monitoring, the expansion of personalized arrhythmia treatment approaches, growing investments in electrophysiology technologies, and an increasing focus on stroke prevention strategies. Key trends influencing this period include the increasing adoption of advanced cardiac mapping technologies, a rising use of catheter ablation procedures, the growing integration of wearable cardiac monitoring devices, the expansion of early diagnosis and screening programs, and an enhanced focus on minimally invasive treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20495&type=smp

Which Drivers Are Expected To Impact The Atrial Flutter Market During The Forecast Period?

The increasing occurrence of cardiovascular diseases is anticipated to fuel the expansion of the atrial flutter market in the future. Cardiovascular diseases (CVDs) encompass a wide array of medical conditions affecting the heart and blood vessels. This rise in cardiovascular diseases is primarily attributable to an aging population, inactive lifestyles, inadequate diets, elevated obesity levels, and stress-related elements. As cardiovascular diseases become more widespread, the population susceptible to atrial flutter expands, thereby increasing the need for diagnostic tools and therapeutic interventions. As an illustration, data from September 2024 by the British Heart Foundation, a cardiovascular research charity based in the UK, indicated that about 7.6 million people in the UK are presently living with heart and circulatory diseases, with 4 million being men and 3.6 million women. Projections suggest that this figure could grow by 1 million by 2030, and potentially by 2 million above current numbers by 2040. Consequently, the growing incidence of cardiovascular diseases is serving as a catalyst for the expansion of the atrial flutter market.

How Is The Atrial Flutter Market Divided Into Segments?

The atrial flutter market covered in this report is segmented –

1) By Type: Typical Atrial Flutter, Atypical Atrial Flutter, Left Atrial Flutter, Reverse Typical Atrial Flutter, Incisional Atrial Re-Entry

2) By Treatment: Antiarrhythmics, Beta-Blockers, Anticoagulants, Cardioversion, Catheter Ablation, Surgery, Other Treatments

3) By Diagnosis: Holter Monitoring, Blood Tests, Electrocardiography (ECG), Event Monitoring, Other Diagnosis

4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

5) By End Users: Clinic, Hospital, Other End Users

Subsegments:

1) By Typical Atrial Flutter: Type I Atrial Flutter (Caval Tricuspid Isthmus Dependent), Type II Atrial Flutter (Right Atrial Macro-Reentry), Focal Typical Atrial Flutter, Post-Surgical Typical Atrial Flutter

2) By Atypical Atrial Flutter: Left Atrial Atypical Flutter, Right Atrial Atypical Flutter, Focal Atypical Flutter, Multifocal Atypical Flutter

3) By Left Atrial Flutter: Left Atrial Macro-Reentry Flutter, Left Atrial Focal Flutter, Left Atrial Flutter Post-Surgery

4) By Reverse Typical Atrial Flutter: Reverse Typical Flutter With Counterclockwise Rotation, Reverse Typical Flutter With Clockwise Rotation, Post-Cardiac Surgery Reverse Typical Flutter

5) By Incisional Atrial Re-Entry: Post-Surgical Atrial Flutter (Incisional Flutter), Incisional Re-Entry Flutter After Cardiac Procedures, Incisional Flutter Due To Atrial Scar Tissue

Which Competitive Trends Are Impacting The Structure Of The Atrial Flutter Market?

Major companies in the atrial flutter market are concentrating on integrating monitoring technologies, such as arrhythmia detection algorithms, to improve diagnostic accuracy, enhance treatment outcomes, and optimize patient management. Arrhythmia detection algorithms are specialized software tools that analyze data from electrocardiograms (ECGs) or wearable heart monitors to identify heart rhythm irregularities and detect abnormal patterns indicative of arrhythmias, including atrial flutter. For instance, in May 2024, Vivalink, Inc., a US-based connected health technology firm, launched a complete ambulatory cardiac monitoring solution for mobile cardiac telemetry (MCT) and Holter monitoring, designed to enhance remote patient care. This solution employs advanced software to continuously analyze data from electrocardiograms (ECGs) and wearable heart monitors, offering real-time identification of irregular heart rhythms such as atrial flutter. The solution includes a reusable electrocardiogram (ECG) patch with a 14-day rechargeable battery and up to 30 days of data storage. It also features a mobile gateway integrated with a patient app for seamless data transmission, an advanced algorithm that detects over 15 arrhythmias, and a clinician portal for in-depth analysis and report customization.

Which Key Players Are Driving Competition In The Atrial Flutter Market?

Major companies operating in the atrial flutter market are Pfizer Inc., Johnson & Johnson, Siemens AG, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Medtronic PLC, Boehringer Ingelheim GmbH, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Astellas Pharma Inc., Zoll Medical Corporation, St. Jude Medical Inc., Biotronik SE & Co., iRhythm Technologies Inc., AtriCure Inc., Adagio Medical Inc., Acutus Medical Inc., Abbott Vascular

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/atrial-flutter-global-market-report

Which Region Is Projected To Lead The Atrial Flutter Market During The Forecast Period?

North America was the largest region in the atrial flutter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial flutter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Atrial Flutter Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20495&type=smp

Browse Through More Reports Similar to the Global Atrial Flutter Market 2026, By The Business Research Company

Wearable Heart Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Implantable Heart Pacemaker Market Report 2026

https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

Heart Pump Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795